GB9827431D0 - Novel compound - Google Patents
Novel compoundInfo
- Publication number
- GB9827431D0 GB9827431D0 GBGB9827431.9A GB9827431A GB9827431D0 GB 9827431 D0 GB9827431 D0 GB 9827431D0 GB 9827431 A GB9827431 A GB 9827431A GB 9827431 D0 GB9827431 D0 GB 9827431D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compound
- novel
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9827431.9A GB9827431D0 (en) | 1998-12-11 | 1998-12-11 | Novel compound |
PCT/GB1999/004176 WO2000035910A1 (fr) | 1998-12-11 | 1999-12-10 | Derive paroxetinique |
JP2000588170A JP2002532494A (ja) | 1998-12-11 | 1999-12-10 | パロキセチンの誘導体 |
AU17888/00A AU1788800A (en) | 1998-12-11 | 1999-12-10 | Derivative of paroxetine |
EP99961195A EP1137646A1 (fr) | 1998-12-11 | 1999-12-10 | Derive paroxetinique |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9827431.9A GB9827431D0 (en) | 1998-12-11 | 1998-12-11 | Novel compound |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9827431D0 true GB9827431D0 (en) | 1999-02-03 |
Family
ID=10844142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9827431.9A Ceased GB9827431D0 (en) | 1998-12-11 | 1998-12-11 | Novel compound |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1137646A1 (fr) |
JP (1) | JP2002532494A (fr) |
AU (1) | AU1788800A (fr) |
GB (1) | GB9827431D0 (fr) |
WO (1) | WO2000035910A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1309557B9 (fr) | 2000-12-29 | 2006-11-15 | Pfizer Limited | Amlodipine hemimaleate |
WO2002053541A1 (fr) | 2000-12-29 | 2002-07-11 | Pfizer Limited | Derive d'amide d'amlodipine |
US6653481B2 (en) | 2000-12-29 | 2003-11-25 | Synthon Bv | Process for making amlodipine |
GB2371862B (en) | 2000-12-29 | 2004-07-14 | Bioorg Bv | Reference standards for determining the purity or stability of amlodipine maleate and processes therefor |
MXPA03005882A (es) | 2000-12-29 | 2005-04-19 | Pfizer Ltd | Derivado amida de amlodipina. |
EP1309556B1 (fr) | 2000-12-29 | 2004-11-24 | Pfizer Limited | Fumarate d'amlodipine |
US7335380B2 (en) | 2000-12-29 | 2008-02-26 | Synthon Ip Inc. | Amlodipine free base |
GB2372036B (en) | 2000-12-29 | 2004-05-19 | Bioorg Bv | Aspartate derivative of amlodipine |
BR0116557A (pt) | 2000-12-29 | 2003-10-28 | Pfizer Ltd | Processo, processo para fabricação de um sal de maleato de amlodipina substancialmente livre de aspartato de amlodipina, processo para purificação, maleato de amlodipina, composição farmacêutica para tratar ou prevenir angina ou hipertenção, método para tratar hipertenção, angina ou ataque cardìaco, benzeno sulfonato de amlodipina, hidrocloreto de amlodipina e uso de maleato de amlodipina substancialmente livre de aspartato de amlodipina |
AT5874U1 (de) | 2000-12-29 | 2003-01-27 | Bioorg Bv | Pharmazeutische zubereitungen enthaltend amlodipinmaleat |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
EP1078925A1 (fr) * | 1997-06-10 | 2001-02-28 | Synthon B.V. | Composés 4-phenylpiperidine |
KR20010040711A (ko) * | 1998-02-06 | 2001-05-15 | 피터 기딩스 | 파록세틴의 염 |
HUP0103651A3 (en) * | 1998-04-09 | 2002-12-28 | Smithkline Beecham Plc | Paroxetine maleate and process for its preparation |
-
1998
- 1998-12-11 GB GBGB9827431.9A patent/GB9827431D0/en not_active Ceased
-
1999
- 1999-12-10 WO PCT/GB1999/004176 patent/WO2000035910A1/fr not_active Application Discontinuation
- 1999-12-10 AU AU17888/00A patent/AU1788800A/en not_active Abandoned
- 1999-12-10 JP JP2000588170A patent/JP2002532494A/ja active Pending
- 1999-12-10 EP EP99961195A patent/EP1137646A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU1788800A (en) | 2000-07-03 |
EP1137646A1 (fr) | 2001-10-04 |
JP2002532494A (ja) | 2002-10-02 |
WO2000035910A1 (fr) | 2000-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9801392D0 (en) | Novel compounds | |
GB0216752D0 (en) | Novel compound | |
GB9805348D0 (en) | Compound | |
GB9827431D0 (en) | Novel compound | |
GB9808268D0 (en) | Compound | |
GB9808896D0 (en) | Novel compound | |
GB9808894D0 (en) | Novel compound | |
GB9823175D0 (en) | Compound | |
GB9817307D0 (en) | Novel compound | |
GB9820404D0 (en) | Novel compound | |
GB9823856D0 (en) | Novel compound | |
GB9821732D0 (en) | Novel compound | |
GB9815871D0 (en) | Novel compound | |
GB9826172D0 (en) | Novel compound | |
GB9817337D0 (en) | Novel compound | |
GB9817323D0 (en) | Novel compound | |
GB9817321D0 (en) | Novel compound | |
GB9817310D0 (en) | Novel compound | |
GB9827277D0 (en) | Novel compound | |
GB9817338D0 (en) | Novel compound | |
GB9802638D0 (en) | Novel compounds | |
GB9800337D0 (en) | Novel compounds | |
GB9802533D0 (en) | Novel compounds | |
GB9802656D0 (en) | Novel compounds | |
GB9802657D0 (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |